MDxHealth SA Logo

MDxHealth SA

MDXH | BR

Overview

Corporate Details

ISIN(s):
BE0974461940
LEI:
549300J3MG9F9B5FY646
Country:
Belgium
Address:
Rue d'Abhooz 31, 4040 Herstal
Sector:
Health Care
Industry:
Biotechnology

Description

Mdxhealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on proprietary genetic, epigenetic and other complex molecular technologies. Mdxhealth is dedicated to providing highly accurate and clinically actionable urologic solutions to inform patient diagnosis and treatment while improving healthcare economics for payers and providers.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2023-12-18 07:00
Regulatory News Service
MDXH PR EN.pdf
English 241.9 KB
2023-12-18 07:00
Regulatory News Service
MDXH PR FR.pdf
French 236.7 KB
2023-11-27 07:00
Regulatory News Service
PR 2023 10 27 EN.pdf
English 249.4 KB
2023-11-27 07:00
Regulatory News Service
PR 2023 10 27 FR.pdf
French 241.5 KB
2023-11-13 22:00
Major Shareholding Notification
MDxHealth - New Denominator (EN).pdf
English 249.5 KB
2023-11-13 22:00
Major Shareholding Notification
MDxHealth - New Denominator (FR).pdf
French 250.1 KB
2023-11-08 22:00
Earnings Release
MDxHealth 3Q23 FINAL EN.pdf
English 288.9 KB
2023-11-08 22:00
Earnings Release
MDxHealth 3Q23 FINAL FR.pdf
French 299.0 KB
2023-11-06 07:00
Declaration of Voting Results & Voting Rights Announcements
EGM results and process (FR).pdf
French 261.5 KB
2023-11-06 07:00
Regulatory News Service
EGM results and process (ENG).pdf
English 259.2 KB
2023-11-06 07:00
General Meeting Notice
EGM Deed (3 November 2023).pdf
French 4.3 MB
2023-11-06 07:00
Regulatory News Service
EGM results and process (ENG).pdf
English 259.2 KB
2023-11-06 07:00
Inside Information Statement
EGM results and process (FR).pdf
French 261.5 KB
2023-10-20 22:00
Major Shareholding Notification
MDxHealth - Press Release (ENG).pdf
English 210.7 KB
2023-10-20 22:00
Transaction in Own Shares
MDxHealth - Press Release (FR).pdf
French 212.8 KB

Insider Transactions

Date Insider Name Position Type Shares Value
2023-09-11 KALFUS RON Executive member Buy 400,000 116,000.00 EUR
2023-09-10 Sollee Joseph Executive member Buy 200,000 58,000.00 EUR
2022-09-26 KALFUS RON Executive member Buy 200,000 136,800.00 EUR
2022-09-23 Sollee Joseph Executive member Buy 200,000 136,800.00 EUR
2021-01-26 SLAGMULDER REGINE Board Buy 78,091 79,653.00 EUR
2021-01-25 SLAGMULDER REGINE Board Buy 212,182 216,298.00 EUR
2020-09-21 SLAGMULDER REGINE Board Buy 52,000 37,824.80 EUR
2020-09-18 SLAGMULDER REGINE Board Buy 10,000 7,223.00 EUR
2020-09-17 SLAGMULDER REGINE Board Buy 4,000 2,860.40 EUR
2020-09-16 SLAGMULDER REGINE Board Buy 7,000 4,988.20 EUR

Peer Companies

Company Country Ticker View
1NKEMIA Logo 1NKEMIA Spain IKM
2cureX AB Logo 2cureX AB Sweden 2CUREX
4SC AG Logo 4SC AG Germany VSC
Abera Bioscience AB Logo Abera Bioscience AB Sweden ABERA
ABIONYX Pharma Logo ABIONYX Pharma France ABNX
Abliva Logo Abliva Sweden ABLI
AB Science Logo AB Science France AB
Acticor Biotech Logo Acticor Biotech France ALACT
Active Biotech Logo Active Biotech Sweden ACTI
AcuCort AB Logo AcuCort AB Sweden ACUC